{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:04:05Z","timestamp":1779771845028,"version":"3.53.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejphar.2026.178964","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:28:55Z","timestamp":1778567335000},"page":"178964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ursocholic acid ameliorates hepatic steatosis via direct AMPK activation in preclinical models of MASLD"],"prefix":"10.1016","volume":"1026","author":[{"given":"Yong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-3697","authenticated-orcid":false,"given":"Weizhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-1417","authenticated-orcid":false,"given":"Danxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-730X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178964_bib1","series-title":"Experientia Supplementum","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-319-43589-3_2","article-title":"Regulation of carbohydrate metabolism, lipid metabolism, and protein metabolism by AMPK","author":"Angin","year":"2016"},{"key":"10.1016\/j.ejphar.2026.178964_bib2","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/ijms20102470","article-title":"Alterations of fatty acid profile may contribute to dyslipidemia in chronic kidney disease by influencing hepatocyte metabolism","volume":"20","author":"Czumaj","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178964_bib3","article-title":"Current trends and future perspectives in the treatment of PBC and PSC: a review","volume":"5","author":"Das","year":"2022","journal-title":"Health Sci. Rev."},{"key":"10.1016\/j.ejphar.2026.178964_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/BST20180625","article-title":"Allosteric regulation of AMP-activated protein kinase by adenylate nucleotides and small-molecule drugs","volume":"47","author":"De Souza Almeida Matos","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejphar.2026.178964_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.103482","article-title":"Sodium butyrate alleviates free fatty acid-induced steatosis in primary chicken hepatocytes via the AMPK\/PPAR\u03b1 pathway","volume":"103","author":"Ding","year":"2024","journal-title":"Poult. Sci."},{"key":"10.1016\/j.ejphar.2026.178964_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/jfbc\/9463646","article-title":"AMPK activation and lipid homeostasis regulation in MASLD: investigating the hepatoprotective and anti-inflammatory effects of meta-capridin medium-chain triglycerides","volume":"2025","author":"Doagoo","year":"2025","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ejphar.2026.178964_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2026.178964_bib8","article-title":"Research progress on AMPK in the pathogenesis and treatment of MASLD","volume":"16","author":"Feng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178964_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.178964_bib10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.178964_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hep.32112","article-title":"Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase\/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice","volume":"75","author":"Fuchs","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2026.178964_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17474124.2018.1399060","article-title":"The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives","volume":"12","author":"Gitto","year":"2017","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178964_bib13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cmet.2013.08.019","article-title":"AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation","volume":"18","author":"Gowans","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2026.178964_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2131\/jts.40.127","article-title":"Aspirin regulates hepatocellular lipid metabolism by activating AMPK signaling pathway","volume":"40","author":"He","year":"2015","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2026.178964_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2036.2011.04695.x","article-title":"Validation of the non-alcoholic fatty liver disease activity score","volume":"34","author":"Hjelkrem","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.178964_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hep.24708","article-title":"Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase\/sterol regulatory element-binding protein 1 signaling in mice","volume":"55","author":"Hu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2026.178964_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101259","article-title":"Direct small molecule ADaM-site AMPK activators reveal an AMPK\u03b33-independent mechanism for blood glucose lowering","volume":"51","author":"J\u00f8rgensen","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejphar.2026.178964_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11901-024-00638-7","article-title":"Cholestatic pruritus: pathophysiology, current management approach, and emerging therapies","volume":"23","author":"Kode","year":"2024","journal-title":"Curr. Hepat. Rep."},{"key":"10.1016\/j.ejphar.2026.178964_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155209","article-title":"Si-Ni-San inhibits hepatic Fasn expression and lipid accumulation in MAFLD mice through AMPK\/P300\/SREBP-1c axis","volume":"123","author":"Lan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.178964_bib20","first-page":"863","article-title":"Natural diosmin alleviating obesity and nonalcoholic fatty liver disease by regulating the activating the AMP-activated protein kinase (AMPK) pathway","volume":"23","author":"Liu","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejphar.2026.178964_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155437","article-title":"Rutin ameliorated lipid metabolism dysfunction of diabetic NAFLD via AMPK\/SREBP1 pathway","volume":"126","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2026.178964_bib22","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.178964_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0016-5085(86)90862-0","article-title":"Effect of ursocholic acid on bile lipid secretion and composition","volume":"90","author":"Loria","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2026.178964_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/onco4020007","article-title":"Inhibitory effects of metformin for pancreatic neuroendocrine neoplasms: experimental study on mitochondrial function","volume":"4","author":"Maruzen","year":"2024","journal-title":"Onco"},{"key":"10.1016\/j.ejphar.2026.178964_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2026.178964_bib26","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3390\/ijms20205171","article-title":"AMPK activation promotes tight junction assembly in intestinal epithelial Caco-2 cells","volume":"20","author":"Olivier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178964_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102314","article-title":"Effectiveness of metformin for the reversal of cold-ischemia-induced damage in hepatosteatosis","volume":"48","author":"Oruc","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178964_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tips.2025.03.008","article-title":"Targeting AMPK as a potential treatment for hepatic fibrosis in MASLD","volume":"46","author":"Palomer","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.178964_bib29","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178964_bib30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178964_bib31","first-page":"20","article-title":"Regulation of AMP-activated protein kinase by natural and synthetic small molecule activators","volume":"3","author":"Ross","year":"2016","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejphar.2026.178964_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113614","article-title":"AMP-activated protein kinase: an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis","volume":"428","author":"Sharma","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2026.178964_bib33","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2026.178964_bib34","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1056\/NEJMe2504717","article-title":"Semaglutide for metabolic dysfunction-associated steatotic liver disease","volume":"392","author":"Simon","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178964_bib35","article-title":"Quantitative chemical proteomics reveals triptolide selectively inhibits HCT116 human colon cancer cell viability and migration through binding to peroxiredoxin 1 and annexin A1","volume":"8","author":"Song","year":"2023","journal-title":"Adv. Biol."},{"key":"10.1016\/j.ejphar.2026.178964_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.178964_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70242-8","article-title":"Efficacy and safety of resmetirom, a selective thyroid hormone receptor-\u03b2 agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"14","author":"Suvarna","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178964_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF02536598","article-title":"Differential effects of ursodeoxycholic acid and ursocholic acid on the formation of biliary cholesterol crystals in mice","volume":"26","author":"Uchida","year":"1991","journal-title":"Lipids"},{"key":"10.1016\/j.ejphar.2026.178964_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/pharma4030014","article-title":"The comparative safety and efficacy of resmetirom and semaglutide in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review","volume":"4","author":"Udaikumar","year":"2025","journal-title":"Pharmacoepidemiology"},{"key":"10.1016\/j.ejphar.2026.178964_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1248\/bpb.b17-00724","article-title":"AMPK-mediated regulation of lipid metabolism by phosphorylation","volume":"41","author":"Wang","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2026.178964_bib41","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1042\/BCJ20170458","article-title":"Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells","volume":"474","author":"Willows","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.178964_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117514","article-title":"Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease","volume":"321","author":"Xu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2026.178964_bib43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178964_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2015.09.006","article-title":"AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1","volume":"417","author":"Yin","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178964_bib45","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/1874467208666150817112109","article-title":"Signal transduction mechanisms of alcoholic fatty liver disease: emerging role of lipin-1","volume":"10","author":"You","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178964_bib46","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2026.178964_bib47","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.178964_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152300","article-title":"Elucidating the mechanistic interplay of AMPK and Nrf2 in MASLD: a focus on dietary phytochemical modulation of lipid and redox homeostasis","volume":"777","author":"Yu","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.178964_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177127","article-title":"Metformin inhibits migration and epithelial-to-mesenchymal transition in non-small cell lung cancer cells through AMPK-mediated GDF15 induction","volume":"985","author":"Zhou","year":"2024","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:26:40Z","timestamp":1779769600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926004462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"alternative-id":["S0014299926004462"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178964","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ursocholic acid ameliorates hepatic steatosis via direct AMPK activation in preclinical models of MASLD","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178964"}}